Ozempic, Mounjaro manufacturers sued over claims of "stomach paralysis" side effects A personal injury law firm has filed a lawsuit against Novo Nordisk and Eli Lilly and Co., the manufacturers of Ozempic and Mounjaro, over claims that the diabetes drugs, which are popular for aiding weight loss, can cause gastroparesis, a paralysis of the stomach
see in-text citations
Verify the order details before submitting
It stated that overall clinical benefit was found in 89% of patients
Frequently asked questions Does Blue Cross Blue Shield of North Carolina cover semaglutide (Wegovy)
[5] [16] This multi-receptor activity drives significant reductions in appetite, caloric intake, and body weight effects that, while therapeutically promising, can also influence how the body regulates temperature